Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $10 Price Target

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $10 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Cybin (AMEX:CYBN) with a Buy and maintains $10 price target.

byBenzinga Newsdesk

March 10, 2023

1 minute read

HC Wainwright & Co. analyst Patrick Trucchio reiterates Cybin (AMEX:CYBN) with a Buy and maintains $10 price target.

Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns

By Vandana Singh

May 22, 11:46 AM

Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia.

LLY

Analyst Ratings

Demystifying Apple: Insights From 21 Analyst Reviews

By Benzinga Insights

March 28, 5:00 PM

Ratings for Apple (NASDAQ:AAPL) were provided by 21 analysts in the past three months, showcasing a mix of…

AAPL

‘Trump Georgia Election Case Halted Pending Outcome Of Challenge To D.A.’ – CNBC

By Benzinga Newsdesk

June 5, 4:52 PM

https://www.cnbc.com/2024/06/05/trump-georgia-election-case-halted-pending-outcome-of-challenge-to-da.htmlA Georgia appeals court put on hold the criminal election case against former President Donald Trump in that

DJT

Citigroup Maintains Neutral on Texas Instruments, Lowers Price Target to $155

By Benzinga Newsdesk

October 26, 10:24 AM

Citigroup analyst Christopher Danely maintains Texas Instruments (NASDAQ:TXN) with a Neutral and lowers the price target from $165 to $155.

TXN

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $10 Price Target

Related Posts

Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns

Demystifying Apple: Insights From 21 Analyst Reviews

‘Trump Georgia Election Case Halted Pending Outcome Of Challenge To D.A.’ – CNBC

Citigroup Maintains Neutral on Texas Instruments, Lowers Price Target to $155